Synlogic, Inc. (NASDAQ:SYBX) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET

Company Participants

Andrew Funderburk - Kendall IR

Aoife Brennan - CEO, President

Michael Jensen - CFO

Tony Awad - COO

Molly Harper - Chief Business Officer

Dave Hava - Chief Scientific Officer

Conference Call Participants

Joseph Schwartz - SVB Securities

Mark Breidenbach - Oppenheimer

Mitchell Kapoor - H.C. Wainwright

Operator

Good morning. Welcome to Synlogic's Second Quarter 2022 Conference Call. At this time all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised, that this call is being recorded.

I would now like to turn the call over to Andrew Funderburk of Kendall Investor Relations. Please proceed.

Andrew Funderburk

Thank you, operator. Good morning, and thank you for joining us on today's conference call. This morning, we issued a press release, which outlines our second quarter 2022 financial results and additional business updates. The release is available on the Investors section of our website at www. synlogictx.com.

Joining me on this call are Dr. Aoife Brennan, President and Chief Executive Officer; Molly Harper, Chief Business Officer; Dave Hava, Chief Scientific Officer; and Michael Jensen, Chief Financial Officer. Other members of the management team will be available during the Q&A.

During the call, Aoife will provide a review of first quarter highlights. Molly will provide additional details for the clinical programs. Dave will discuss our earlier-stage programs and collaborations, and Michael will provide a financial overview. Following our prepared remarks, we will open the call for questions.

As we begin, I'd like to remind everyone that comments today may include forward-looking statements made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date hereof and are subject to numerous factors, assumptions, risks and uncertainties, which change over time. Actual results could differ materially from those contained in any forward-looking statements as a result of various factors, including those described under the heading Forward-Looking Statements in Synlogic's press release from earlier today or under the heading Risk Factors in Synlogic's most recent Form 10-K or in later filings with the SEC. Synlogic cautions you not to place undue reliance on any forward-looking statements.

Now I'd like to turn the call over to Aoife.

Aoife Brennan

Thanks, Andrew. Good morning, everyone, and thank you for joining us. I'm happy to share update today on our recent progress, the financial results for the second quarter of 2022 and upcoming milestones.